PROTOCOL 3V2640-CLIN-005Investigator's Agreement • March 22nd, 2021
Contract Type FiledMarch 22nd, 2021This is a multi-center, randomized, single-blind, placebo-controlled, dose-escalation study to evaluate the safety and efficacy of TVB-2640 in subjects with NASH. Male and female subjects aged